Stay updated on PANDORE Clinical Trial: Pembrolizumab in Bladder Cancer
Sign up to get notified when there's something new on the PANDORE Clinical Trial: Pembrolizumab in Bladder Cancer page.

Latest updates to the PANDORE Clinical Trial: Pembrolizumab in Bladder Cancer page
- CheckyesterdayChange DetectedA funding attribution note for the 2016 U.S. NIH grant/contract was added. The page revision tag was updated from v3.6.5 to v3.6.6.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page's revision indicator changed from v3.6.4 to v3.6.5, reflecting a background update to the ClinicalTrials.gov interface while the study details remain the same.SummaryDifference0.1%

- Check36 days agoChange DetectedRevision label on the page updated from v3.6.3 to v3.6.4. This reflects a software update to the site rather than a modification to the study information or user-facing content.SummaryDifference0.1%

- Check58 days agoChange DetectedThe page's revision label was updated from v3.6.2 to v3.6.3, indicating a new published version of the page.SummaryDifference0.1%

- Check66 days agoChange DetectedThe study page shows a new revision label (v3.6.2), indicating a recent update to the record that supersedes the previous version (v3.6.0).SummaryDifference0.1%

- Check80 days agoChange DetectedRecruitment status was updated to indicate no participant enrollment; new help and navigation sections were added, and the Intervention/Treatment heading was standardized, with the revision tag updated to v3.6.0.SummaryDifference0.5%

Stay in the know with updates to PANDORE Clinical Trial: Pembrolizumab in Bladder Cancer
Enter your email address, and we'll notify you when there's something new on the PANDORE Clinical Trial: Pembrolizumab in Bladder Cancer page.